Angioarchitectural Factors Associated with Postoperative Cerebral Infarction in Ischemic Moyamoya Disease

Objective: To investigate the angioarchitectural factors associated with postoperative cerebral infarction in ischemic moyamoya disease. Methods: Data on patients who underwent surgery for ischemic MMD from 1 October 2015 to 31 October 2020, at Peking University International Hospital were collected and retrospectively analyzed. General conditions such as patient sex, age, site of surgery, preoperative manifestations such as TIA attack and old cerebral infarction, and seven angioarchitectural factors of the MMD based on DSA were selected and measured. Statistical analysis was performed by the Pearson chi-square statistic, analysis of variance (ANOVA), and multifactor logistic regression analysis. Results: Age (OR, 0.969; 95%CI, 0.939–1.000; p = 0.049), A1stenosis (OR, 5.843; 95%CI, 1.730–19.732; p = 0.004), M1stenosis (OR, 6.206; 95%CI, 2.079–18.526; p = 0.001), PCA anomalies (OR, 4.367; 95%CI, 1.452–13.129; p = 0.049), Unstable compensation (OR, 5.335; 95%CI, 1.427–19.948; p = 0.013), TIA (OR, 4.264; 95%CI, 1.844–9.863; p = 0.001), Old cerebral infarction (OR, 2.972; 95%CI, 1.194–7.397; p = 0.019). The above seven factors can be used in the regression equation to predict the probability of postoperative cerebral infarction. The prediction accuracy is 90.2%. Conclusions: Age, TIA attack, old cerebral infarction, and five angioarchitectural factors of MMD are strongly associated with postoperative cerebral infarction. Seven factors, including age, TIA attack, old infarction, and four angioarchitectural factors, can be taken to quantify the probability of surgical cerebral infarction in MMD.

[1]  T. Wakabayashi,et al.  Postoperative stroke and neurological outcomes in the early phase after revascularization surgeries for moyamoya disease: an age-stratified comparative analysis , 2021, Neurosurgical Review.

[2]  M. Kawashima,et al.  Effectiveness of combined direct and indirect revascularization for moyamoya disease with concurrent congenital rubella syndrome. , 2020, World neurosurgery.

[3]  K. Ogasawara,et al.  Revascularisation surgery improves cognition in adult patients with moyamoya disease , 2019, Journal of Neurology, Neurosurgery, and Psychiatry.

[4]  J. Wellons,et al.  Surgical outcomes for pediatric moyamoya: a systematic review and meta-analysis. , 2019, Journal of neurosurgery. Pediatrics.

[5]  Qian Zhang,et al.  Clinical Features and Surgical Outcomes of Patients With Moyamoya Disease and the Homozygous RNF213 p.R4810K Variant , 2019, Journal of child neurology.

[6]  N. Mikuni,et al.  Influence of Inflammatory Disease on the Pathophysiology of Moyamoya Disease and Quasi-moyamoya Disease , 2019, Neurologia medico-chirurgica.

[7]  M. Ranjan,et al.  Surgery for Moyamoya Disease in Children , 2019, Journal of child neurology.

[8]  Rong Wang,et al.  Revascularization Surgery in Patients with Ischemic-Type Moyamoya Disease: Predictors for Postoperative Stroke and Long-Term Outcomes. , 2019, World neurosurgery.

[9]  Jun Yu,et al.  Risk factors for postoperative stroke in adults patients with moyamoya disease: a systematic review with meta-analysis , 2019, BMC Neurology.

[10]  P. Muthusami,et al.  Childhood Moyamoya: Looking Back to the Future. , 2019, Pediatric neurology.

[11]  Tej D. Azad,et al.  Validation and Application for the Berlin Grading System of Moyamoya Disease in Adult Patients. , 2019, Neurosurgery.

[12]  K. Houkin,et al.  Trends of Antiplatelet Therapy for the Management of Moyamoya Disease in Japan: Results of a Nationwide Survey. , 2018, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[13]  S. Lam,et al.  Indirect revascularization with the dural inversion technique for pediatric moyamoya disease: 20-year experience. , 2018, Journal of neurosurgery. Pediatrics.

[14]  X. Ji,et al.  Progress in moyamoya disease , 2018, Neurosurgical Review.

[15]  S. Miyamoto,et al.  Late Cerebrovascular Events and Social Outcome after Adolescence: Long-term Outcome of Pediatric Moyamoya Disease , 2018, Neurologia medico-chirurgica.

[16]  G. Worley,et al.  Speculation on the naming of Moyamoya disease. , 2018, Journal of neuroradiology. Journal de neuroradiologie.

[17]  Qian Zhang,et al.  Encephaloduroateriosynangiosis versus conservative treatment for patients with moyamoya disease at late Suzuki stage , 2018, Journal of Clinical Neuroscience.

[18]  Ji-zong Zhao,et al.  The Collateral Circulation in Moyamoya Disease: A Single-Center Experience in 140 Pediatric Patients. , 2017, Pediatric neurology.

[19]  Qian Zhang,et al.  Effect of Aspirin in Postoperative Management of Adult Ischemic Moyamoya Disease. , 2017, World neurosurgery.

[20]  Qian Zhang,et al.  Long-Term Outcome After Conservative Treatment and Direct Bypass Surgery of Moyamoya Disease at Late Suzuki Stage. , 2017, World neurosurgery.

[21]  G. Steinberg,et al.  Direct Versus Indirect Bypass for Moyamoya Disease. , 2017, Neurosurgery clinics of North America.

[22]  O. Kwon,et al.  Hemodynamic Changes after Unilateral Revascularization for Moyamoya Disease: Serial Assessment by Quantitative Magnetic Resonance Angiography , 2017, Neurosurgery.

[23]  Zhen-Ni Guo,et al.  Etiology and pathogenesis of Moyamoya Disease: An update on disease prevalence , 2017, International journal of stroke : official journal of the International Stroke Society.

[24]  P. Ferroli,et al.  Vasculogenic and Angiogenic Pathways in Moyamoya Disease. , 2016, Current medicinal chemistry.

[25]  Wei-Wei Liu,et al.  Surgical outcomes following encephaloduroarteriosynangiosis in adult moyamoya disease associated with Type 2 diabetes. , 2016, Journal of neurosurgery.

[26]  C. Tolias,et al.  Moyamoya angiopathy – Is there a Western phenotype? , 2015, British journal of neurosurgery.

[27]  T. Tominaga,et al.  Current status of revascularization surgery for Moyamoya disease: special consideration for its 'internal carotid-external carotid (IC-EC) conversion' as the physiological reorganization system. , 2015, The Tohoku journal of experimental medicine.

[28]  S. Lee,et al.  Indications and Outcomes of Prophylactic and Therapeutic Extracranial-to-intracranial Arterial Bypass for Cerebral Revascularization , 2015, Plastic and reconstructive surgery. Global open.

[29]  T. Tominaga,et al.  Diagnosis of Moyamoya Disease: International Standard and Regional Differences , 2015, Neurologia medico-chirurgica.

[30]  S. Kuroda Asymptomatic Moyamoya Disease: Literature Review and Ongoing AMORE Study , 2015, Neurologia medico-chirurgica.

[31]  S. Miyamoto,et al.  Cognitive Dysfunction Survey of the Japanese Patients with Moyamoya Disease (COSMO-JAPAN Study): Study Protocol , 2015, Neurologia medico-chirurgica.

[32]  S. Kuroda,et al.  The frequency of postoperative stroke in moyamoya disease following combined revascularization: a single-university series and systematic review. , 2014, Journal of neurosurgery.

[33]  C. Derdeyn,et al.  Advances and surgical considerations in the treatment of moyamoya disease. , 2014, Neurosurgery.

[34]  Edward R. Smith,et al.  Vascular collateralization along ventriculoperitoneal shunt catheters in moyamoya disease. , 2013, Journal of neurosurgery. Pediatrics.

[35]  S. Kuroda,et al.  Review of past research and current concepts on the etiology of moyamoya disease. , 2012, Neurologia medico-chirurgica.

[36]  G. Steinberg,et al.  Neurosurgical Advances in the Treatment of Moyamoya Disease , 2011, Stroke.

[37]  Tariq Parray,et al.  Moyamoya Disease: A Review of the Disease and Anesthetic Management , 2011, Journal of neurosurgical anesthesiology.

[38]  R. Guzman,et al.  Intraoperative Blood Flow Analysis of Direct Revascularization Procedures in Patients with Moyamoya Disease , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[39]  R. Scott,et al.  Moyamoya disease and moyamoya syndrome. , 2009, The New England journal of medicine.

[40]  M. Fukui Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. , 1997, Clinical neurology and neurosurgery.

[41]  M. Fukui,et al.  `Angiographic Moyamoya' its definition, classification, and therapy , 1997, Clinical Neurology and Neurosurgery.